Cogent Biosciences (NASDAQ:COGT) reported quarterly earnings results on February 17, 2026 that fell short of analyst expectations. The Healthcare company reported earnings per…
Cogent Biosciences (NASDAQ:COGT) reported quarterly earnings results on February 17, 2026 that fell short of analyst expectations.
The Healthcare company reported earnings per share of $-0.61, missing the consensus estimate of $-0.51 by $0.10 per share. Revenue came in at , meeting the estimate of .
Cogent Biosciences's stock moved following the earnings release. The stock currently trades at $37.80 with a market capitalization of $5.7B.
Our Markets Team monitors market data, SEC filings, analyst actions, earnings releases, and corporate announcements to produce timely updates for investors.
Current market data
NASDAQ · COGT
$34.08
Down: -$0.67 · -1.97%
Live quote updated
Keep reading
price ·
analyst ·
analyst ·
earnings ·
